The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients Article

Troike, Katie M, de la Rocha, Arlet M Acanda, Alban, Tyler J et al. (2021). The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients . 13(18), 10.3390/cancers13184525

Open Access

cited authors

  • Troike, Katie M; de la Rocha, Arlet M Acanda; Alban, Tyler J; Grabowski, Matthew M; Otvos, Balint; Cioffi, Gino; Waite, Kristin A; Sloan, Jill S Barnholtz; Lathia, Justin D; Guilarte, Tomas R; Azzam, Diana J

sustainable development goals

authors

publication date

  • September 1, 2021

keywords

  • 18 KDA TSPO
  • APOPTOSIS
  • BINDING-PROTEIN
  • BRAIN
  • EXPRESSION
  • HUMAN ASTROCYTOMAS
  • Life Sciences & Biomedicine
  • MICROGLIAL ACTIVATION
  • MITOCHONDRIAL
  • Oncology
  • PERIPHERAL BENZODIAZEPINE-RECEPTORS
  • PROLIFERATION
  • Science & Technology
  • TSPO
  • biomarker
  • glioblastoma
  • single nucleotide polymorphism
  • survival

Digital Object Identifier (DOI)

publisher

  • MDPI

volume

  • 13

issue

  • 18